The Biggest AI Medical Breakthrough since Ozempic

This Countertop Device Could Change Healthcare Forever

November 04, 2025

*Together with HyphaLabs

This Biotech Just Unlocked a Massive Health Opportunity

We're entering a new era of health where artificial intelligence doesn't just live on your phone – it lives on your kitchen counter.

Hypha Labs, a public biotech innovator, has developed a sleek, powerful, home device called the AI Accelerator. And it's nothing short of a game changer.

No complex setup. No medical background needed. Just load a cartridge and let the system grow targeted wellness compounds based on your needs.

What sets this apart isn't just the science – it's the accessibility. The AI Accelerator is designed to bring the future of medicine directly to the consumer, with clinical-grade precision and usability that rivals your favorite kitchen appliance.

This platform isn't just for one product. It's a system that can scale – both in homes and commercially – to produce highly targeted mushroom-derived compounds for the wellness, supplement, and beverage markets.

In short, this isn't just a device. It's a new category in personal healthcare technology. One that removes the gatekeepers and puts the power of personalized healing directly in the hands of consumers.

Why this matters:

  • First-of-its-kind AI-powered countertop bio-manufacturing platform

  • Controls temp, airflow, humidity, and sterility with surgical precision

  • No lab experience required – fully automated growing cycle

  • Cloud-connected and continuously learning across user base

  • B2B expansion opportunity in supplements, beverages, and wellness products

  • Still open at $0.20/share – but only until November 5

Hypha Labs is reshaping what it means to control your own health environment.

This is a paid advertisement for HyphaLabs's Regulation A offering. Please read the offering circular at invest.hyphalabs.com

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer: https://bullseyealerts.com/disclaimer/

SPONSORED CONTENT & COMPENSATION: We have been paid two thousand eight hundred dollars by IMS to increase public awareness of HyphaLabs. You should assume we receive compensation for any non-SV purchases through links in this email via affiliate relationships, direct/indirect payments from companies or third parties who may own stock in or have other interests in promoted companies ("Clients"). We may purchase, sell, or hold long or short positions without notice in securities mentioned in this communication.

CLIENT CONTENT: SV is not responsible for any content hosted on Client sites; it is the Client's responsibility to ensure compliance with applicable laws.

NOT INVESTMENT ADVICE: Content is for educational, informational, and advertising purposes only and should NOT be construed as securities-related offers or solicitations. All content, regardless of characterization as "educational," should be considered promotional and subject to disclosed conflicts of interest. Do NOT rely on this as personalized investment advice. SV strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS NOT TYPICAL: Past performance, testimonials, and historical results are unverified and NOT indicative of future results. Results presented are NOT guaranteed as TYPICAL. Past newsletters, marketing materials, track records, case studies, and promotional content should NOT be relied upon as indication of future performance. Market conditions, regulatory environments, and individual circumstances vary significantly over time. Actual results will vary widely given factors such as experience, skill, risk mitigation practices, market dynamics and capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

REGULATORY STATUS: Neither SV nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

HIGH-RISK SECURITIES: Securities discussed may be penny stocks, small-cap stocks, cryptocurrencies, options, or other highly speculative investments subject to extreme price volatility, rapid and substantial price movements, limited liquidity, regulatory changes, and potential total loss of value. Market conditions can change rapidly and unpredictably.

LEGAL: In any legal action arising from or related to SV services or these terms, SV shall be entitled to recover attorneys' fees, costs, and disbursements in addition to any other relief.